Comparison of oral flora before and after triple therapy for Helicobacter pylori eradication in patient with gastric disease
The oral cavity is recognized as a major route for infection by Helicobacter pylori, which colonizes the gastric mucosa. Therapeutic options for elimination in patients with digestive disease have been established, though whether antibiotics are effective for H. pylori harbored in the oral cavity as well as oral commensal bacteria remain unknown. A 29-year-old woman visited a gastrointestinal clinic with a chief complaint of stomach ache. Gastroscopy and urine test findings for H. pylori IgG led to a definitive diagnosis of goose bumps gastritis induced by bacteria in the stomach, and triple therapy for H. pylori eradication was administered. Oral samples were obtained 10 times at a dental hospital clinic from 1 week before until 6 months after starting triple therapy. Nested PCR amplifying the ureA gene and PCR assays using species-specific primer sets were performed to detect H. pylori and major oral commensal bacterial species, respectively, in those samples. Bacterial DNA encoding the ureA gene of H. pylori in oral specimens was detected prior to starting therapy, which was then reduced during and not detected after finishing treatment. Although the populations of major oral pathogenic bacteria, such as periodontopathic and oral streptococcal species, were drastically reduced during triple therapy, most had recovered within approximately 1 week after ending treatment. These results suggest that a conventional triple therapy approach for eradication of H. pylori in cases of digestive disease is effective for elimination of the bacterium from the oral cavity. On the other hand, after finishing such therapy, the oral flora composition is not drastically changed.
KeywordsHelicobacter pylori Eradication therapy Molecular biological analysis Oral specimens Oral bacteria
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The study protocol was approved by the Ethics Committee of Osaka University Graduate School of Dentistry (Approval Number: H23-E1-5).
- 6.Tiwari SK, Khan AA, Ahmed KS, Ali SM, Ahmed I, Habeeb A, Kauser F, Hussain MA, Ahmed N, Habibullah CM. Polymerase chain reaction based analysis of the cytotoxin associated gene pathogenicity island of Helicobacter pylori from saliva: an approach for rapid molecular genotyping in relation to disease status. J Gastroenterol Hepatol. 2005;20:1560–6.CrossRefGoogle Scholar
- 11.Vahedi M, Khalilian A, Abdollahzadeh S, Shafiei N. Saliva secretion and efficacy of Helicobacter Pylori eradication in peptic ulcer patients. J Dent. 2011;8:165–9 (Tehran University of Medical Sciences, Tehran).Google Scholar
- 14.Robert J, Palmer JR. Composition and development of oral bacterial communities. Periodontol 2000. 2013;64:20–39.Google Scholar
- 30.Adamsson I, Nord CE, Lundquist P, Sjostedt S, Edlund C. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother. 1999;44:629–40.CrossRefGoogle Scholar
- 35.Nomura R, Nakano K, Nemoto H, Fujita K, Inagaki S, Takahashi T, Taniguchi K, Takeda M, Yoshioka H, Amano A, Ooshima T. Isolation and characterization of Streptococcus mutans in heart valve and dental plaque specimens from a patient with infective endocarditis. J Med Microbiol. 2006;55:1135–40.CrossRefGoogle Scholar